Low-Dose Metronomic Chemotherapy: Myth or Truth?
نویسندگان
چکیده
منابع مشابه
Combining low-dose or metronomic chemotherapy with anticancer vaccines
Therapeutic vaccination is regarded as a promising strategy against multiple hematological malignancies including lymphoma. However, this approach alone possesses limited potential for the treatment of established tumors. As several anticancer regimens relies on the combination of multiple drugs, it is reasonable to predict that also cancer vaccination will be most effective in the context of m...
متن کاملImproving conventional or low dose metronomic chemotherapy with targeted antiangiogenic drugs.
One of the most significant developments in medical oncology practice has been the approval of various antiangiogenic drugs for the treatment of a number of different malignancies. These drugs include bevacizumab (Avastin), the anti-VEGF monoclonal antibody. Thus far, bevacizumab appears to induce clinical benefit in patients who have advanced metastatic disease only or primarily when it is com...
متن کاملstrategies for comprehensions truth or myth
the study of learning strategies had been the focus of attention of many language specialist in recent years and many researchers showed their significance in attainmg mastery of second language skills. the current explosion of research on reading strategies aim at finding out the thoughts that drift through the reader's mind, the quest and endeavor for meaning, the representations and ass...
متن کاملIsolated pulmonary valve endocarditis: truth or myth?
Pulmonary valve (PV) infective endocarditis (IE) is an extremely rare disease that involves normal as well as abnormal valves. This condition mostly occurs in patients with underlying predisposing factors. It could be missed if patients do not present with typical features of right-sided endocarditis or in the absence of classic risk factors. The case presented here did not have any known risk ...
متن کاملStandard cystectomy fits all: truth or myth?
Radical cystectomy (RC) with pelvic lymph node dissection (PLND) followed by urinary diversion is the treatment of choice for muscle-invasive bladder cancer (BC) and non-invasive BC refractory to transurethral resection of the bladder (TUR-B) and/or intravesical instillation therapies. Since the morbidity and possible mortality of this surgery are relevant, care must be taken in the preoperativ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Oncology Research and Treatment
سال: 2006
ISSN: 2296-5270,2296-5262
DOI: 10.1159/000093971